NEAM
EVGN icon

New England Asset Management’s Evogene EVGN Stock Holding History

New England Asset Management’s Portfolio EVGN Stock Details EVGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-1,500
Closed -$76K – 153
2017
Q2 		$76K Hold
1,500
– – ﹤0.01% 135
2017
Q1 		$80K Hold
1,500
– – ﹤0.01% 163
2016
Q4 		$77K Buy
+1,500
New +$85.8K ﹤0.01% 185

Other funds holding EVGN

WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
MCM
Moon Capital Management New York $166M AUM 54.85% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return
SM
Senvest Management New York $3.01B AUM 35.7% 1-Year Est. Return

New England Asset Management's EVGN Position: Q3 2017 in Review

New England Asset Management sold out of Evogene (EVGN) in Q3 2017, closing a stake of 1,500 shares — an estimated $76K sold.

New England Asset Management first reported a position in EVGN in Q4 2016 and held it in 3 quarters. The position peaked at $80K in Q1 2017. 19 funds tracked by Wall St. Rank hold EVGN as of Q3 2017.

  • New England Asset Management reported no remaining Evogene position as of Q3 2017 after selling out during the quarter.
  • New England Asset Management sold 1,500 Evogene shares in Q3 2017, an estimated $76K.
  • New England Asset Management first reported a position in Evogene in Q4 2016 and held it in 3 quarters.
  • New England Asset Management's Evogene position peaked at $80K in Q1 2017.
  • 19 funds tracked by Wall St. Rank held Evogene as of Q3 2017.

Based on New England Asset Management's 13F filing for Q3 2017, filed 14 Nov 2017.